才錦麟,阿力亞,何強(qiáng)(中山大學(xué)附屬第一醫(yī)院肝膽外科,廣東廣州510080)
慢病毒介導(dǎo)的GATA6基因沉默對(duì)肝癌Huh-7細(xì)胞凋亡的影響*
才錦麟,阿力亞,何強(qiáng)△
(中山大學(xué)附屬第一醫(yī)院肝膽外科,廣東廣州510080)
目的:研究GATA6基因沉默對(duì)肝癌Huh-7細(xì)胞凋亡的影響,同時(shí)探討可能的作用機(jī)制。方法:構(gòu)建靶向GATA6基因的慢病毒干擾載體,用流式細(xì)胞術(shù)確定轉(zhuǎn)染效率,用RT-PCR和Western blotting法檢測(cè)其對(duì)人類肝細(xì)胞癌細(xì)胞株Huh-7的干擾效果,流式細(xì)胞術(shù)檢測(cè)細(xì)胞凋亡比例,Western blotting法檢測(cè)各轉(zhuǎn)染組Huh-7細(xì)胞NF-κB及Bcl-2蛋白表達(dá)。結(jié)果:靶向GATA6基因的慢病毒干擾載體感染肝癌Huh-7細(xì)胞后,轉(zhuǎn)染效率為57.4%。GATA6在mRNA和蛋白水平的表達(dá)明顯下降。GATA6沉默的肝癌Huh-7細(xì)胞凋亡比例增加(P<0.05),NF-κB和Bcl-2蛋白水平表達(dá)降低。結(jié)論:利用慢病毒載體干擾技術(shù)沉默GATA6基因的表達(dá)可以明顯促進(jìn)Huh-7細(xì)胞凋亡,其機(jī)制可能通過NF-κB信號(hào)通路調(diào)節(jié)凋亡相關(guān)蛋白的表達(dá),進(jìn)而影響細(xì)胞的凋亡。靶向GATA6的RNA干擾技術(shù)在肝癌的基因治療中具有一定的研究?jī)r(jià)值。
GATA6基因;慢病毒;RNA干擾;肝細(xì)胞癌
[ABSTRACT]AIM:To explore the effectof GATA6 gene silencing on apoptosis of hepatocellular carcinoma Huh-7 cells.METHODS:RNA interference vectors of the targetgene GATA6 mediated by lentiviruswere constructed in vitro to transfect the hepatocellular carcinoma cell line Huh-7.The apoptotic rate of transfected cellswasmeasured by flow cytometry.The protein expression of GATA6,NF-κB and Bcl-2 in transfected cells was determined by Western blotting.RESULTS:The transfection efficiency was 57.4%.ThemRNA and protein expression of GATA6 reduced significantly after the carcinoma cell line Huh-7 being transfected by RNA interference vectorsmediated by lentivirus.The apoptotic rate of the carcinoma cellswith silent GATA6 genewas significantly increased(P<0.05).The protein expression levels of NF-κB and Bcl-2 were also significantly decreased.CONCLUSION:Lentiviral vector-mediated RNA interference of GATA6 has an inhibitory effecton the expression of the gene itself,and promotes the apoptosis of hepatocellular carcinoma cells.Regulation of the apoptosis-related protein expression by the NF-κB signaling to influence the proliferation and apoptosis of hepatocellular carcinoma cellsmight be one of the possiblemechanisms.
[KEY WORDS]GATA6 gene;Lentivirus;RNA interference;Hepatocellular carcinoma
人類GATA結(jié)合蛋白6(GATA binding protein 6,GATA6)基因定位于18q11.1-q11.2,其編碼蛋白GATA6含有2個(gè)特殊的蛋白質(zhì)二級(jí)結(jié)構(gòu)——鋅指結(jié)構(gòu)。這2個(gè)鋅指結(jié)構(gòu)域能結(jié)合特定的核苷酸序列(A/T)GATA(A/T)[1]。在正常的個(gè)體發(fā)育階段,GATA6可直接與心肌組織的肌鈣蛋白轉(zhuǎn)錄增強(qiáng)子結(jié)合,調(diào)節(jié)肌鈣蛋白的表達(dá);同時(shí)聯(lián)系經(jīng)典Wnt/β-catenin和非經(jīng)典Wnt/JNK信號(hào)通路[2],促進(jìn)心肌組織成熟,在正常心血管系統(tǒng)和消化系統(tǒng)特異性分化與器官形成中發(fā)揮重要促進(jìn)作用,是胚胎期發(fā)育中重要的調(diào)控基因[3]。
近年來,在膽管癌、卵巢癌等實(shí)體腫瘤中均發(fā)現(xiàn)GATA6的異常表達(dá),且與腫瘤的分期和預(yù)后相關(guān)[4-5]。研究報(bào)道GATA6在結(jié)腸癌的發(fā)病及疾病進(jìn)展中發(fā)揮關(guān)鍵作用[6]。GATA6表現(xiàn)出作為腫瘤治療靶點(diǎn)潛在的可能性。本文旨在探討沉默GATA6后對(duì)Huh-7細(xì)胞的抑制作用及可能的途徑,為臨床上治療肝癌提供新的思路。
1細(xì)胞株和菌株
本實(shí)驗(yàn)采用人類肝細(xì)胞癌細(xì)胞株Huh-7(購(gòu)自中山大學(xué)實(shí)驗(yàn)動(dòng)物中心),用含10%胎牛血清的DMEM培養(yǎng)液,在37℃、5%CO2恒溫培養(yǎng)箱進(jìn)行培養(yǎng)。慢病毒構(gòu)建及包裝中使用的腎上皮293T細(xì)胞和大腸桿菌菌株DH5α,均購(gòu)自上海吉?jiǎng)P基因化學(xué)有限公司。293T細(xì)胞用含10%胎牛血清的DMEM培養(yǎng)液,在37℃、5%CO2恒溫培養(yǎng)箱進(jìn)行培養(yǎng)。兔抗人GATA6多克隆抗體、鼠抗人NF-κB單克隆抗體和兔抗人Bcl-2單克隆抗體均為Santa Cruz產(chǎn)品。
2GATA6基因RNA干擾慢病毒載體制備及感染細(xì)胞
慢病毒載體質(zhì)粒PGCSIL-GFP、pHelper 1.0和pHelper 2.0均購(gòu)自上海吉?jiǎng)P基因化學(xué)有限公司。實(shí)驗(yàn)分3組:(1)隨機(jī)對(duì)照組(NC組);(2)空白對(duì)照組(control組);(3)實(shí)驗(yàn)組(shGATA6組)。構(gòu)建并合成shRNA干擾片段:正義鏈5’-GGGAAUUCAAACCAGGAAAUU-3’,反義鏈3’-UUCCCUUAAGUUUGGUCCUUU-5’,把合成的引物干粉溶解于退火緩沖液中,90℃水浴15 min,然后自然冷卻至室溫,形成帶黏性末端的雙鏈。將shRNA和PGCSIL-GFP進(jìn)行酶切連接,制備和鑒定克隆后,以Qiagen公司的質(zhì)粒抽提試劑盒提取慢病毒包裝系統(tǒng)中3種質(zhì)粒DNA,用293T細(xì)胞進(jìn)行病毒包裝。5 d后在熒光顯微鏡下進(jìn)行觀察并拍照,確定感染效率,流式細(xì)胞術(shù)定量。
3流式細(xì)胞術(shù)分析細(xì)胞凋亡率
收集各組細(xì)胞,PBS緩沖液洗滌,胰酶消化,調(diào)整細(xì)胞密度至5×108/L,加入500μL binding buffer懸浮細(xì)胞,分別加入10μL AnnexinV-FITC和10μL PI混勻,室溫避光孵育染色15 min,用FACS流式細(xì)胞儀進(jìn)行雙色熒光細(xì)胞流式計(jì)數(shù),觀察凋亡細(xì)胞的百分比。
4RT-PCR法檢測(cè)GATA6 m RNA表達(dá)水平
轉(zhuǎn)染細(xì)胞至24 h時(shí),每組各取6孔細(xì)胞,Trizol法提取總RNA,按逆轉(zhuǎn)錄試劑盒說明逆轉(zhuǎn)錄獲取cDNA,PCR儀擴(kuò)增。GATA6上游引物5’-CTCAGTTCCTACGCTTCGCAT-3’,下游引物5’-GTCGAGGTCAGTGAACAGCA-3’。內(nèi)參照GAPDH上游引物5’-ACCACAGTCCATGCCATCAC-3’,下游引物5’-TCCACCACCCTGTTGCTGTA-3’。反應(yīng)條件:94℃5 min;40個(gè)循環(huán),94℃45 s,57.5℃30 s,72℃10 min。PCR產(chǎn)物經(jīng)1.5%瓊脂糖凝膠電泳檢測(cè),凝膠成像。
5Western blotting檢測(cè)
分別取接種在6孔板的對(duì)數(shù)生長(zhǎng)期的慢病毒感染后的Huh-7細(xì)胞,用經(jīng)過預(yù)冷的PBS緩沖液洗滌細(xì)胞2次。用濾紙吸凈PBS液后,每孔加入100μL RIPA裂解液+1μL PMSF。充分裂解后,用離心機(jī)于20 000×g、4℃下離心30min,上清液即為蛋白提取液。用BCA蛋白定量試劑盒(Pierce)測(cè)定樣品蛋白濃度。將樣品煮沸10 min變性。蛋白上樣量50 μg,以10%SDS-聚丙烯酰胺凝膠電泳分離蛋白,電泳轉(zhuǎn)移至NC膜,置于5%脫脂奶粉(TBST配制)中室溫封閉1 h。各轉(zhuǎn)染組分別加入GATA6抗體(1∶100),NF-κB抗體(1∶500),Bcl-2(1∶500)或GAPDH抗體(1∶1 000),4℃過夜。用TBST漂洗3次,每次10 min。加入HRP標(biāo)記羊抗鼠Ⅱ抗或羊抗兔Ⅱ抗,室溫下于搖床孵育2 h。再次用TBST洗膜后,ECL發(fā)光法顯色,X線片曝光。
6統(tǒng)計(jì)學(xué)處理
用SPSS 16.0統(tǒng)計(jì)軟件進(jìn)行分析。數(shù)據(jù)用均數(shù)±標(biāo)準(zhǔn)差(mean±SD)表示,多組間比較采用單因素方差分析(ANOVA)。以P<0.05為差異有統(tǒng)計(jì)學(xué)意義
1肝細(xì)胞癌Huh-7細(xì)胞株中GATA6干擾慢病毒的感染效率
為了研究肝癌細(xì)胞中GATA6基因的作用,我們選用GATA6基因表達(dá)水平較高的Huh-7細(xì)胞進(jìn)行GATA6基因沉默。Huh-7細(xì)胞鋪6孔板,24 h后加慢病毒感染。熒光顯微鏡下隨機(jī)選取視野,并對(duì)同一視野的細(xì)胞同時(shí)進(jìn)行明視野和熒光視野的拍照,對(duì)比確定感染效率,利用流式細(xì)胞術(shù)定量檢測(cè)轉(zhuǎn)染效率為57.4%,見圖1。
Figure 1.Huh-7 cellswere infected with the GATA6-RNAi lentivirus for 96 h(×100).圖1 GATA6-RNAi慢病毒感染Huh-7細(xì)胞
2Western blotting和RT-PCR驗(yàn)證GATA6沉默的效率
為了了解感染了慢病毒的肝癌Huh-7細(xì)胞內(nèi)源性GATA6 mRNA和蛋白表達(dá)水平的改變,我們利用RT-PCR和Western blotting法對(duì)慢病毒感染的Huh-7細(xì)胞GATA6 mRNA和蛋白表達(dá)水平進(jìn)行測(cè)定。結(jié)果發(fā)現(xiàn)慢病毒感染Huh-7細(xì)胞后能有效降低內(nèi)源性GATA6 mRNA(圖2A)和蛋白(圖2B)水平,差異有統(tǒng)計(jì)學(xué)意義(P<0.05)。
Figure 2.RT-PCR analysis of GATA6 mRNA levels(A)and Western blotting analysis of GATA6 protein levels(B)in NC group,control group and experimental group.Mean±SD.n=3.*P<0.05 vs NC group and control group.圖2 GATA6 m RNA及蛋白在各組細(xì)胞中的表達(dá)
3慢病毒介導(dǎo)的GATA6沉默促進(jìn)肝癌Huh-7細(xì)胞凋亡
慢病毒介導(dǎo)的GATA6沉默組的細(xì)胞凋亡率為(27.10±2.75)%,空白對(duì)照組和陰性對(duì)照組細(xì)胞凋亡率分別為(7.76±0.41)%和(7.70±0.45)%,實(shí)驗(yàn)組細(xì)胞凋亡率較空白對(duì)照組和陰性對(duì)照組明顯升高(P<0.05),差異有統(tǒng)計(jì)學(xué)意義,見圖3。
Figure 3.Flow cytometry of cell apoptosis in NC group,control group and experimental group.Mean±SD.n=3.*P<0.05 vs NC group and control group.圖3 流式細(xì)胞術(shù)檢測(cè)各組細(xì)胞的凋亡情況
4慢病毒介導(dǎo)GATA6沉默可能通過NF-κB和Bcl-2途徑促進(jìn)Huh-7細(xì)胞凋亡
為了探討GATA6基因抑制凋亡的分子調(diào)控機(jī)制,慢病毒感染Huh-7細(xì)胞后,我們利用Western blotting法分析Huh-7細(xì)胞GATA6以及重要凋亡相關(guān)分子NF-κB和Bcl-2蛋白表達(dá)水平,以GAPDH蛋白作內(nèi)參照。結(jié)果顯示,GATA6沉默后,與對(duì)照組比較,GATA6、NF-κB和Bcl-2蛋白表達(dá)量均明顯降低,差異有統(tǒng)計(jì)學(xué)意義(P<0.05),見圖4。
Figure 4.Western blotting analysis of NF-κB and Bcl-2 proteins in NC group,control group and experimental group.Mean±SD.n=3.*P<0.05 vs NC group and control group.圖4 各組細(xì)胞NF-κB與BCL-2蛋白的表達(dá)
NF-κB與基因啟動(dòng)子區(qū)的固定核苷酸序列結(jié)合而啟動(dòng)基因轉(zhuǎn)錄功能,從而調(diào)節(jié)許多重要的生理過程,包括急性期炎癥免疫反應(yīng)細(xì)胞的生長(zhǎng)凋亡和腫瘤的形成。NF-κB通過上調(diào)許多抗凋亡相關(guān)蛋白,比如Bcl-2蛋白的表達(dá)而發(fā)揮抑制腫瘤細(xì)胞凋亡的作用[7]。Colo等[8]研究發(fā)現(xiàn)在人類慢性粒細(xì)胞白血病K562細(xì)胞中GATA6敲除能引起NF-κB表達(dá)下調(diào)從而促進(jìn)凋亡的發(fā)生。
在人類大多數(shù)腫瘤細(xì)胞中,GATA6的表達(dá)增高是常見的事件。GATA6在人類胰腺上皮內(nèi)瘤變組織及胰腺癌組織中高表達(dá),進(jìn)一步研究表明GATA6的拷貝數(shù)量與胰腺癌患者的預(yù)后密切相關(guān)[9]。在本研究中,我們成功構(gòu)建了抑制GATA6基因的慢病毒表達(dá)載體,并包裝成為病毒顆粒。再用病毒顆粒轉(zhuǎn)染肝癌Huh-7細(xì)胞,證實(shí)了轉(zhuǎn)染的效率,并發(fā)現(xiàn)Huh-7細(xì)胞中GATA6的表達(dá)下調(diào)。通過MTT實(shí)驗(yàn)發(fā)現(xiàn)肝癌細(xì)胞生長(zhǎng)明顯受到抑制,流式細(xì)胞術(shù)發(fā)現(xiàn)細(xì)胞凋亡比例增加。以上結(jié)果表明,下調(diào)GATA6的表達(dá)能夠明顯抑制細(xì)胞增殖,提高細(xì)胞凋亡。為了探討GATA6影響細(xì)胞凋亡的機(jī)制,我們從蛋白水平分析了凋亡相關(guān)蛋白的表達(dá)情況。Western blotting結(jié)果顯示NF-κB和Bcl-2蛋白水平明顯下降,以上結(jié)果表明:GATA6可能通過調(diào)控NF-κB和Bcl-2蛋白來影響細(xì)胞的凋亡過程。
90%以上的胰腺癌細(xì)胞,由于Wnt信號(hào)通路激活,提高了GATA6的表達(dá),進(jìn)而加速EGFR和AKT的磷酸化,導(dǎo)致NF-κB的表達(dá)增加以及活性增強(qiáng)。持續(xù)活化的NF-κB促進(jìn)細(xì)胞生長(zhǎng)、侵襲和轉(zhuǎn)移相關(guān)基因的持續(xù)表達(dá),最終導(dǎo)致腫瘤的發(fā)生[10]。在部分結(jié)腸細(xì)胞中,抑癌因子microRNA-365表達(dá)受到抑制,從了促使了GATA6的激活,進(jìn)一步促進(jìn)了GPR49(G-protein coupled receptor 49)與NF-κB的活化,在結(jié)腸細(xì)胞的腫瘤化過程中起關(guān)鍵作用。GATA6作為一個(gè)促癌基因,當(dāng)它的表達(dá)受到抑制時(shí),進(jìn)一步抑制NF-κB與Bcl-2的表達(dá),導(dǎo)致細(xì)胞凋亡相關(guān)基因轉(zhuǎn)錄水平的下降,抑制了細(xì)胞的凋亡進(jìn)程[4]。
在少數(shù)組織細(xì)胞中,GATA6表現(xiàn)為一個(gè)抑癌基因。研究表明,在人類惡性膠質(zhì)瘤組織中,導(dǎo)致GATA6基因失效的關(guān)鍵突變,而正常人類腦膠質(zhì)組織中未發(fā)現(xiàn)GATA6的突變。體外實(shí)驗(yàn)中,沉默膠質(zhì)細(xì)胞的GATA6基因,能夠增加VEGF表達(dá),加速膠質(zhì)細(xì)胞腫瘤化過程,GATA6表現(xiàn)出抑制腫瘤進(jìn)展的作用[11]。
GATA6作為一個(gè)促癌基因,其機(jī)制被廣泛討論。GATA6特異的鋅指結(jié)構(gòu)能與特異的G蛋白結(jié)合,促進(jìn)尿激酶型纖溶酶原激活物的活化,提高了癌細(xì)胞的侵襲和轉(zhuǎn)移能力[12]。還有文獻(xiàn)報(bào)道,下調(diào)GATA6的表達(dá),可以提高活性氧簇的生成,進(jìn)而阻滯胰腺癌細(xì)胞的增殖[13]。在本研究中,我們發(fā)現(xiàn)GATA6基因在肝癌Huh-7細(xì)胞中起促癌作用,抑制肝癌Huh-7細(xì)胞凋亡的作用可能是促進(jìn)NF-κB與Bcl-2的表達(dá),以上結(jié)果為肝癌基因治療提供新的靶點(diǎn)。
[1]Morrisey EE,Ip HS,Lu MM,etal.GATA-6:a zinc finger transcription factor that is expressed in multiple cell lineages derived from lateral mesoderm[J].Dev Biol,1996,177(1):309-322.
[2]Zhang Y,Goss AM,Cohen ED,et al.A Gata6-Wnt pathway required for epithelial stem cell development and airway regeneration[J].Nat Genet,2008,40(7):862-870.
[3]Koutsourakis M,Langeveld A,Patient R,et al.The transcription factor GATA6 is essential for early extraembryonic development[J].Development,1999,126(4):723-732.
[4]Tian F,Li D,Chen J,et al.Aberrant expression of GATA binding protein 6 correlates with poor prognosis and promotes metastasis in cholangiocarcinoma[J].Eur J Cancer,2013,49(7):1771-1780.
[5]Cai KQ,Caslini C,Capo-chichi CD,et al.Loss of GATA4 and GATA6 Expression Specifies Ovarian Cancer Histological Subtypes and Precedes Neoplastic Transformation of Ovarian Surface Epithelia[J].PLoSOne,2009,4(7): e6454.
[6]Tsuji S,Kawasaki Y,F(xiàn)urukawa S,et al.The miR-363-GATA6-Lgr5 pathway is critical for colorectal tumourigenesis[J].Nat Commun,2014,5:3150.
[7]Sen R,Baltimore D.Inducibility ofκimmunoglobulin enhancer-binding protein NF-κB by a posttranslationalmechanism[J].Cell,1986,47(6):921-928.
[8]Colo GP,Rosato RR,Grant S,et al.RAC3 down-regulation sensitizes human chronic myeloid leukemia cells to TRAIL-induced apoptosis[J].FEBS Lett,2007,581 (26):5075-5081.
[9]Kwei KA,Bashyam MD,Kao J,et al.Genomic profiling identifies GATA6 as a candidate oncogene amplified in pancreatobiliary cancer[J].PLoS Genet,2008,4(5): e1000081.
[10]Zhong Y,Wang Z,F(xiàn)u B,etal.GATA6 activatesWntsignaling in pancreatic cancer by negatively regulating the Wnt antagonist Dickkopf-1[J].PLoSOne,2011,6(7): e22129.
[11]Kamnasaran D,Qian B,Hawkins C,et al.GATA6 is an astrocytoma tumor suppressor gene identified by gene trapping ofmouse gliomamodel[J].Proc Natl Acad Sci U S A,2007,104(19):8053-8058.
[12]BelaguliNS,Aftab M,RigiM,etal.GATA6 promotes colon cancer cell invasion by regulating urokinase plasminogen activator gene expression[J].Neoplasia,2010,12 (11):856-864.
[13]Huang FT,Chen WB,Zhang YY,et al.MiRNA-mediated knockdown of GATA6 upregulates reactive oxygen species and inhibits SW1990 pancreatic cancer cell growth in vitro[J].JGastroenterol Hepatol,2012,27(Suppl 5):352-353.
Effects of GATA6 silencing mediated by lentivirus on apoptosis of human liver cancer Huh-7 cells
CAIJin-lin,Aliya,HE Qiang
(Department of Hepatobiliary Surgery,The First Affiliated Hospital,Sun Yat-sen University,Guangzhou 510080,China.E-mail:lheqiang@hotmail.com)
R363
A
10.3969/j.issn.1000-4718.2015.05.030
1000-4718(2015)05-0938-05
2015-01-19[修回日期]2015-04-20
廣東省教育廳自然科學(xué)研究計(jì)劃項(xiàng)目(No.2009B030801175)
Tel:020-87755766;E-mail:lheqiang@hotmail.com